Pancreatic Cancer Genomics 2.0: Profiling Metastases. Read more about Pancreatic Cancer Genomics 2.0: Profiling Metastases.
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma. Read more about A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.
Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics. Read more about Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Read more about Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Cholesterol: An Achilles' Heel for Glioblastoma? Read more about Cholesterol: An Achilles' Heel for Glioblastoma?
Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. Read more about Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.
An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency. Read more about An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
Intratumoral Heterogeneity of the Epigenome. Read more about Intratumoral Heterogeneity of the Epigenome.
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Read more about N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. Read more about Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.